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ABSTRACT
Light-chain deposition disease is a rare paraproteinaemia characterized by deposition of monoclonal light-chain immunoglobulins with a non-
amyloid structure, most frequently affecting the kidney. The authors present the case of a 58-year-old man admitted due to haemorrhagic 
shock caused by spontaneous splenic rupture. Investigation showed coagulopathy, homogeneous hepatomegaly with elevated cholestasis 
enzymes but normal bilirubinaemia, and a nephrotic syndrome with monoclonal kappa light chains. Liver and bone marrow biopsies revealed 
light-chain deposition disease. Splenic rupture as the presentation of a paraproteinaemia is rare. The diagnosis of light-chain deposition 
disease should be considered in case of a monoclonal plasma cell disorder with Congo-red negative deposits on histology.
LEARNING POINTS
• Spontaneous splenic rupture is a rare presentation of a paraproteinaemia.
•	 Light-chain	deposition	disease	is	a	rare	disease	with	non-fibrillar	deposition	of	monoclonal	light-chain	immunoglobulins	most	frequently	
affecting the kidney.
• Light-chain deposition disease should be suspected in case of a monoclonal plasma cell disorder with Congo-red negative deposits on 
histology.
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INTRODUCTION
Light-chain deposition disease (LCDD), heavy-chain deposition disease, and light- and heavy-chain deposition disease are a rare group of 
paraproteinaemias	characterized	by	 the	deposition	of	monoclonal	 immunoglobulins	with	a	non-fibrillar	 structure	and	hence	Congo-red	
negative deposits[1, 2]. The authors describe the diagnostic pathway of a 58-year-old man diagnosed with LCDD following splenic rupture.
CASE PRESENTATION
A 58-year-old man presented to the emergency department with a 1-day history of left back pain that evolved to generalized abdominal 
pain, coffee-ground vomiting and prostration. There was no recent trauma. The patient was a smoker, with a previous peptic ulcer, was 
medicated with bromazepam for insomnia, and had consumed 50 g of alcohol daily until 6 months previously.
On admission, he was hypotensive (89/56 mmHg), tachycardic (99 bpm), pale and with pain in the upper quadrants on abdominal palpation, 
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with	guarding.	A	peptic	ulcer	was	initially	suspected,	but	abdominal	radiography	did	not	show	free	gas.	The	nasogastric	tube	drainage	fluid	
consisted of gastric contents with a small amount of digested blood. A laboratory investigation (Table 1) showed lactic acidosis, acute anaemia, 
coagulopathy, acute kidney failure with hyperkalaemia, and elevated cholestasis enzymes. Abdominal CT (Fig. 1) revealed splenic rupture 
with possible splenic infarction, an exuberant haemoperitoneum and homogeneous hepatomegaly measuring 17 cm. The haemorrhagic 
shock due to spontaneous splenic rupture required an emergent total splenectomy.
Table 1. Laboratory investigation results *Value outside the normal range
Value Normal Range
Haemoglobin (g/dl) 9.1* (13.2–17.2)
Leukocytes (/l) 16.90*×109 (4.0–10.0)
Neutrophils 85%* (55–75)
Platelets (/l) 393×109 (150–400)
Glucose (mg/dl) 238* (70–110)
Urea (mg/dl) 101* (17–43)
Creatinine (mg/dl) 201* (0.8–1.3)
Sodium (mmol/l) 134* (136–145)
Potassium (mmol/l) 5.5* (3.5–5.1)
Total bilirubin (mg/dl) 0.3 (0.3–1.2)
Direct bilirubin (mg/dl) 0.16 (0–5)
Alkaline phosphatase (IU/l) 253* (30–120)
Gamma-glutamyl transferase (IU/l) 412* (<55)
Aspartate aminotransferase (IU/l) 22 (8–35)
Alanine aminotransferase (IU/l) 37 (10–45)
Amylase (IU/l) 21 (22–80)
C-reactive protein (mg/dl) 0.89 (0–51)
Prothrombin time (s) 28.2* 11.3
INR 2.47*
Activated partial prothrombin time (s) 45.9* 29.0
Lactates (mmol/l) 2.6* <2.0
Figure 1. Abdominal computerized tomography: Splenic rupture with an area of possible splenic infarction, large 
subcapsular splenic hematoma, exuberant hemoperitoneum and homogenous hepatomegaly of 17cm
The patient had a good clinical evolution in the post-operative period except for worsening of the coagulopathy (PT 31.8 s, INR 2.78 and 
aPTT 53.9 s) with no bleeding, and elevation of cholestasis enzymes (alkaline phosphatase 535 IU/l and gamma-glutamyl transferase 418 
IU/l).
The initial work-up did not reveal the aetiology of the liver disease, but did exclude viral hepatitis, haemochromatosis, Wilson’s disease, 
alpha1-antitrypsin	deficiency	and	drug	consumption.	A	normal	platelet	count,	transaminases	and	bilirubinaemia	made	alcoholic	liver	disease	
less likely, despite the previous alcohol consumption. However, there was marked hypoproteinaemia (4.1 g/dl) with hypoalbuminaemia (2.1 
g/dl), dyslipidaemia (total cholesterol 270 mg/dl) and hypogammaglobulinaemia on serum protein electrophoresis. Despite the bleeding, 
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fibrinogen	was	normal,	ruling	out	consumption	coagulopathy.	An	abdominal	ultrasound	showed	homogeneous	hepatomegaly	and	a	normal	
biliary tract and excluded hepatic vascular complications. In a broader investigation, an immunological study was negative but urinalysis 
revealed massive proteinuria. There were 9.8 g of protein in the 24-hour urine and so a nephrotic syndrome was diagnosed (nephrotic 
proteinuria,	dyslipidaemia,	hypoalbuminaemia	and	probable	splenic	thrombosis).	The	lack	of	significant	oedema	was	explained	by	treatment	
with	furosemide,	prescribed	in	the	presumed	context	of	excessive	intravenous	fluids.	An	infiltrative	disease	was	suspected	because	of	the	
pattern of liver disease with nephrotic syndrome.
Magnetic resonance cholangiopancreatography exhibited slight peribiliary oedema, while stool examination for parasites was negative, 
as	 was	 alpha-fetoprotein.	 Regarding	 the	 nephrotic	 syndrome,	 despite	 the	 hypogammaglobulinaemia,	 serum	 immunofixation	 revealed	
monoclonal	 IgA	 kappa,	 monoclonal	 kappa	 light	 chains	 were	 detected	 in	 immunofixed	 urinary	 protein,	 and	 the	 serum	 free	 light-chain	
ratio was abnormal (9.06). Serum angiotensin-converting enzyme, serum calcium and 24-hour calciuria were normal and a more detailed 
immunological study remained negative. To evaluate the coagulopathy, an aPTT mix 1:1 showed normalization of aPTT, indicating a factor 
deficiency,	later	identified	as	factor	X	deficiency	(levels	0.03	U/ml,	4%).
The	spleen	histology	which	previously	showed	splenic	phleboliths	was	revised	but	was	negative	 for	 infiltrative	disease	and	was	Congo-
red negative, as was an abdominal fat biopsy. The coagulopathy postponed the decision to carry out an organ biopsy but at this point, 
the patient was submitted to a transjugular liver biopsy with administration of prothrombin complex concentrate. Histology (Figs. 2 and 
3) revealed acidophilic amorphous deposits in the stroma of hepatic lobules, with atypical Congo-red staining and birefringence but with 
immunohistochemistry positive for kappa light chains. An initial diagnosis of amyloidosis was assumed.
Figure 2. Liver biopsy histology, Hematoxylin-eosin staining, 10x: Portal and peripostal 
inflammatory infiltrate and acidophilic amorphous deposits surrounding the hepatocytes
Figure 3. Liver biopsy histology, Congo-red staining, 20x: Amorphous deposits with 
atypical positivity
As	 part	 of	 the	 characterization	 of	 the	 amyloidosis,	 a	 bone	marrow	 study	 showed	 0.3%	monoclonal	 kappa	 light-chain	 plasmocytes	 and	
infiltration	of	the	bone	marrow	by	an	amorphous,	hyaline	material,	negative	for	Congo-red	staining	but	positive	for	kappa	light	chain	on	
immunohistochemistry. Following histology review, light-chain deposition disease was diagnosed.
The patient started chemotherapy with cyclophosphamide, bortezomib and dexamethasone, but shortly afterwards developed progressive 
renal failure and is currently on dialysis.
DISCUSSION
Spontaneous spleen rupture is a rare event in a paraproteinaemia, namely amyloidosis, and was the initial manifestation of amyloidosis in 
71%	of	cases[3].	There	seems	to	be	an	association	with	factor	X	deficiency[3].	Factor	X	deficiency	is	a	rare	coagulopathy	that	can	be	congenital	
or acquired[4].	Acquired	factor	X	deficiency	is	usually	due	to	vitamin	K	antagonists	or	a	plasma	cell	dyscrasia,	such	as	amyloidosis[4].
LCDD,	a	rare	disease	of	non-fibrillar	deposition	of	monoclonal	light-chain	immunoglobulins,	usually	manifests	in	the	fifth	or	sixth	decade	
of life with a male predominance, but the incidence is unknown[2].	In	LCDD,	the	monoclonal	light	chains	are	of	the	kappa	subtype	in	92%	of	
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cases and it is typically associated with multiple myeloma or other lymphoproliferative disorders[2]. The kidney is the main affected organ, 
presenting	with	hypertension,	kidney	failure,	proteinuria	and	haematuria	with	62%	of	cases	requiring	dialysis[1, 2]. However, involvement of 
other organs such as the heart, the liver and neural involvement, has also been described[2].
Without treatment, kidney failure will evolve to end-stage renal disease, but treatment options for LCDD are limited[1, 5]. Steroids and 
melphalan, high-dose melphalan, autologous stem cell transplantation and, more recently, bortezomib-based chemotherapy, are some of 
the treatment options[5]. The median estimated length of survival for treated patients is 14 years[1].
The authors have described this case with an interesting diagnostic pathway to highlight spontaneous spleen rupture as a rare presentation 
of plasma cell disorders, and LCDD as a diagnosis to consider in Congo-red negative, amorphous deposits.
